About
Souvignier performs scientific and business analysis of early-stage biomedical investment opportunities and manages a portfolio of RCT projects and investments, focusing on life science tools and therapeutics. He has held roles at RCT since 2003, previously worked at Guilford Pharmaceuticals, and holds a Ph.D. in Materials Science and an MBA from the University of Arizona.
Invests in
BiotechHealthtechMedical Devices
Investments
Board seats
Biolog, Inc.Calosyn Pharmaceuticals Inc.Esperance Pharmaceuticals, Inc.Halo Labs, Inc.Jenrin Discovery Inc.Seqwell, IncTD2
As listed on the firm's website.
Colleagues at Research Corporation Technologies
Avi Roop
Managing Director at Research Corporation Technologies
Brad Morie
Senior Director, Biotechnologies at Research Corporation Technologies
Christopher P. Martin
President, Medical Devices and CFO at Research Corporation Technologies
Danielle Wilson
Director of Administration & Corporate Secretary at Research Corporation Technologies
David A. Wiersma
Senior Associate at Research Corporation Technologies
Jorge Figueroa
Systems Administrator at Research Corporation Technologies
Kathleen M. Hunter-Gregory
Controller at Research Corporation Technologies
Maggie Zhou
Associate Controller at Research Corporation Technologies